Jong-Mook Kim
21Patents
5h-index
51Co-inventors
72Inventor score
Filing activity: Jan 14, 2000 → Jul 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7422874B2 | Expression vector for animal cell | Chemistry; Metallurgy | 15 | Expired |
| US6451595B1 | High efficiency retroviral vectors that contain none of viral coding sequences | Chemistry; Metallurgy | 10 | Expired |
| US7175840B2 | Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof | Chemistry; Metallurgy | 8 | Expired |
| US7812146B2 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | Human Necessities | 6 | Active |
| US9573991B2 | Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses | Physics | 5 | Active |
| US7745174B2 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | Human Necessities | 5 | Active |
| US8338385B2 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | Human Necessities | 5 | Active |
| US7838505B2 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | Human Necessities | 3 | Active |
| US8106158B2 | Compositions and methods for fusion protein separation | Chemistry; Metallurgy | 2 | Active |
| US8389492B2 | Lyophilized DNA formulations for enhanced expression of plasmid DNA | Human Necessities | 2 | Active |
| US12173304B2 | Intron fragments | Emerging Cross-Sectional Technologies | 1 | Active |
| US7585943B2 | Compositions and methods for fusion protein separation | Chemistry; Metallurgy | 1 | Expired |
| US9834594B2 | Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses | Physics | 1 | Active |
| US9963493B2 | Gene therapy for diabetic neuropathy using an HGF isoform | Human Necessities | 1 | Active |
| US8772021B2 | Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3′ terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector | Chemistry; Metallurgy | 0 | Active |
| US6838280B2 | Construction of high efficiency retroviral vector for gene therapy of hunter syndrome | Chemistry; Metallurgy | 0 | Expired |
| USRE48404E1 | Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor | General | 0 | Active |
| US11007136B2 | Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum | Human Necessities | 0 | Active |
| US9309519B2 | Method for selecting a high expression recombinant cell line | Chemistry; Metallurgy | 0 | Active |
| US10759841B2 | Gene therapy for diabetic neuropathy using an HGF isoform | Human Necessities | 0 | Active |
| US12215338B2 | Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.